Related Experiment Video
Updated: Jul 4, 2026
10:00
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
[An integrated biological model for interferon signaling pathway and its gene polymorphisms]
Jian-Jun Cui1, Geng-Shan Tian, Di Tian
1Department of Infectious Disease, Peking University First Hospital, Beijing 100034, China. cuijianjun0123@163.com
Yi Chuan = Hereditas
|June 14, 2008
Summary
This study developed a systemic structural model of interferon (IFN) signaling pathways, incorporating gene single nucleotide polymorphisms (SNPs). The model reveals complex gene interactions influencing IFN roles and therapeutic potential.
Area of Science:
- Immunology and Genetics
- Computational Biology and Bioinformatics
Context:
- Interferon (IFN) signaling pathways are crucial for immune responses, viral defense, and cell regulation.
- Understanding gene-gene interactions and genetic variations like single nucleotide polymorphisms (SNPs) is vital for elucidating IFN pathway functions.
Purpose:
- To construct a systemic structural model of IFN signaling pathways integrating gene information and SNPs.
- To investigate the impact of gene-gene interactions and SNPs on the biological roles of different IFN types (Type I, II, and III).
Summary:
- A biological systemic structural model for IFN signaling pathways was successfully developed using Teranode Design Suite (TDS) and SNP Trawler software.
- The model encompasses JAK-STAT, MAPK-p38, and PI3K pathways, detailing 98 genes and 19,693 SNPs, illustrating a complex gene-gene interaction network.
- Different IFN types utilize distinct pathway combinations: Type I (JAK-STAT, MAPK-p38, PI3K), Type II (JAK-STAT, MAPK-p38), and Type III (PI3K).
Impact:
- This model facilitates in-depth research into how SNPs affect IFN biological functions and aids in predicting therapeutic efficacy.
- It lays a foundation for translational medicine, drug target discovery, and novel drug development in IFN-related research.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...